期刊文献+

非体外循环冠状动脉旁路移植术围术期输血的术前预测 被引量:3

Preoperative prediction of perioperative transfusion in off-pump coronary artery bypass graft
下载PDF
导出
摘要 目的探讨非体外循环冠状动脉旁路移植术(OPCAB)围术期输血的术前预测指标。方法回顾分析了120例行OPCAB患者的临床资料,通过受试者工作曲线(ROC)分析红细胞比容(Hct)体重乘积预测围术期输血的最佳临界值及预测围术期输血发生的灵敏度和特异度。结果 120例病例对照研究的患者术后输血15例,发病率为12.5%,ROC曲线下面积0.836,根据ROC曲线选定22.559为最佳临界值,预测围术期输血的灵敏度为47.38%,特异度95.88%。结论 Hct体重乘积对OPCAB围术期输血有较强的预测意义,Hct体重乘积>22.559的患者OPCAB围术期输血发生率低。 Objective To identifypreoperativeprediction index of perioperative transfusion in off-pump coronary artery bypassgraft.Methods Clinical data was retrospectively collected and analyzed from patients who underwent off-pump coronary artery bypassgraft(OPCAB) between August 2014 and December 2014.Receiver operating characteristic curve(ROC) was used to estimate optimaloperating point( OOP), sensitivity and specifility for predicting preoperative transfusion.Results The morbidity of perioperativetransfusion in retrospective clinical data was 12.5%. Area under the curve of ROC was 0.836. Meanwhile, 22.559 was selected as OOPbased on ROC.The sensitivity and specifility of predicting preoperative transfusion were 47.38% and 95.88% respectively.Conclusion Product of hct and weight on the preoperativeprediction of perioperative transfusion in OPCAB is powerful. The morbidity of perioper-ative transfusion in OPCABis lower when Product of hct and weight is more than 22.559.
出处 《中国体外循环杂志》 2016年第1期34-36,共3页 Chinese Journal of Extracorporeal Circulation
基金 辽宁省科技攻关计划(2012225005)
关键词 非体外循环冠状动脉旁路移植 围术期输血 冠心病 Off-pump coronary artery bypass graft Perioperative transfusion Coronary heart disease
  • 相关文献

参考文献8

二级参考文献43

  • 1王强,陈敏,陈绍洋,巩固,熊利泽,雷毅,熊东方.非体外循环下冠状动脉旁路移植术对输血和凝血功能的影响[J].陕西医学杂志,2005,34(6):652-655. 被引量:2
  • 2刘杰,林一帆,张沥,胡家露,曹晓燕,樊代明.图象自动分析检测MG7抗原表达预测胃癌高危价值探讨[J].中华预防医学杂志,1996,30(5):286-288. 被引量:13
  • 3宇传华 徐勇勇.ROC分析的基本原理[J].中华流行病学杂志,1998,19(2):413-415.
  • 4Roberts SR, Early GL, Brown B, et al. Autotransfusion of unwashed mediastinal shed blood fails to decrease banked blood requirements in patiments undergoing aortocoronary bypass surgery. Am J Surg, 1991,162 (5) : 477 - 480.
  • 5Goodnough LT. Blood conservation and blood transfusion practices: flip sides of the same coin. Ann Thorac Surg, 1993, 56:3-4.
  • 6Scott MG, Kucik DF, Goodnough LT, et al. Blood substitutes: evolution and future applications. Clin Chem, 1997, 43 (9): 1724- 1731.
  • 7Korn RL, Fisher CA, Livingston ER, et al. The effects of Carmeda Biocactive Surface on human blood components during simulated extracorporeal ciculation. J Thorac Cardiovasc Surg, 1996, 111 (5):1073- 1084.
  • 8Hunt B J, Parratt RN, Segal HC, et al. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg, 1998,65 (3): 712-718.
  • 9Kestin AS, Valefi CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood, 1993, 82 (1): 107-117.
  • 10Wahba A, Rothe G, Lodes H, et al. The influence of the duration of cardiopulmonary bypass on coagulation, fibfinolysis and platelet function. Thorac Cardiovasc Surg, 2001, 49 (3): 153- 156.

共引文献177

同被引文献9

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部